Suchergebnisse - "Szalay, Balázs"

PubPharm (56)

1

Risk Estimation of Gestational Diabetes Mellitus in the First Trimester

enthalten in: The Journal of clinical endocrinology and metabolism | 2023

von Gerszi, D. | Orosz, G. | Török, M. | +8

2

EDTA-Induced Pseudothrombocytopenia up to 9 Months after Initial COVID-19 Infection Associated with Persistent Anti-SARS-CoV-2 IgM/IgG Seropositivity

enthalten in: Laboratory medicine | 2022

von Bereczki, D. | Nagy, B. | Kerényi, A. | +7

3

Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity

enthalten in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals | 2021

von Burcsár, S. | Toldi, G. | Kovács, L. | +3

4

Vitamin D Deficiency has no Impact on PSA Reference Ranges in a General University Hospital - A Retrospective Analysis

enthalten in: EJIFCC | 2020

von Tóth, Z. | Szalay, B. | Gyarmati, B. | +3

5

Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2019

von Ilias, A. | Szanto, K. | Gonczi, L. | +10

6

The Impact of Anti-TNF Therapy on CD4+ and CD8+ Cell Subsets in Ankylosing Spondylitis

enthalten in: Pathobiology : journal of immunopathology, molecular and cellular biology | 2018

von Dulic, S. | Vasarhelyi, Z. | Bajnok, A. | +4

7

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

enthalten in: Inflammatory bowel diseases | 2017

von Gonczi, L. | Gecse, K. | Vegh, Z. | +23

8

High titers of anti-infliximab antibody do not interfere with Abbott immunoassays

enthalten in: Clinical chemistry and laboratory medicine | 2017

von Jo, I. | Szalay, B. | Végh, Z. | +3

9

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

enthalten in: BMC gastroenterology | 2017

von Gonczi, L. | Kurti, Z. | Rutka, M. | +8

10

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

enthalten in: BMC gastroenterology | 2017

von Gonczi, L. | Kurti, Z. | Rutka, M. | +8

1
2
3
4
5
6
Nächster »
[6]